首页 › 基金 › Soleus Capital Management, L.P. › ETON
Soleus Capital Management, L.P. 对 ETON 的持仓历史
ETON PHARMACEUTICALS INC · 医疗保健
Soleus Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 ETON(ETON PHARMACEUTICALS INC)308,101 股,市值约 US$15.9M,约占其申报组合的 0.56%,在其申报持仓中市值排名第 43 位。 Soleus Capital Management, L.P. 最近 6 个申报季度中有 4 个季度披露了 ETON 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Soleus Capital Management, L.P. 对 ETON 的持仓演变
Soleus Capital Management, L.P. 于 Q2 2025 首次披露 ETON 持仓:285,000 股(约 US$4.1M)。 该持仓在 Q3 2026 达到峰值 308,101 股,市值约 US$15.9M。 在 4 次申报中,Soleus Capital Management, L.P. 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 308,101 股、市值约 US$15.9M。 持仓曾出现大幅变动:Q3 2025 减持约 30% (随后一个季度股价下跌 22%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 285.00K | $4.06M | 新进 |
| Q3 2025 | 200.00K | $4.35M | 减持 |
| Q1 2026 | 166.38K | $4.11M | 新进 |
| Q3 2026 | 308.10K | $15.86M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ETON 与 13F 数据
ETON(ETON PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 ETON,申报仓位最大的包括:EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ETON 的基金
- EcoR1 Capital, LLC 2.47M 股 · $127.23M · Q3 2026
- Opaleye Management Inc. 2.86M 股 · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 875.51K 股 · $45.08M · Q3 2026
- National Philanthropic Trust 492.11K 股 · $25.34M · Q3 2026
- Westside Investment Management, Inc. 401.38K 股 · $20.67M · Q3 2026
- Pillsbury Lake Capital LLC 288.27K 股 · $14.84M · Q3 2026
- Panoramic Capital, LLC 192.65K 股 · $9.92M · Q3 2026
- Lumbard & Kellner, LLC 173.26K 股 · $8.92M · Q3 2026
- Grandeur Peak Global Advisors, LLC 161.83K 股 · $8.33M · Q3 2026
- Prospect Capital Advisors, LLC 145.90K 股 · $7.51M · Q3 2026
- Informed Momentum Co LLC 139.21K 股 · $7.17M · Q3 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 97.58K 股 · $5.02M · Q3 2026
更多关于 Soleus Capital Management, L.P.
常见问题
How long has Soleus Capital Management, L.P. held ETON?
Soleus Capital Management, L.P. has disclosed ETON holdings in 4 of the last 6 reported quarters, going back to Q2 2025.
What is Soleus Capital Management, L.P.'s current position in ETON?
As of Q3 2026, Soleus Capital Management, L.P. holds 308.10K shares of ETON (ETON PHARMACEUTICALS INC), valued at $15.86M, representing 0.56% of its reported portfolio and ranking #43.
Has Soleus Capital Management, L.P. been buying or selling ETON?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. newly opened its position in ETON. The position peaked in Q3 2026 at 308.10K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.